Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |